Literature DB >> 12646625

The molecular basis for the lack of immunostimulatory activity of vertebrate DNA.

Katryn J Stacey1, Greg R Young, Francis Clark, David P Sester, Tara L Roberts, Shalin Naik, Matthew J Sweet, David A Hume.   

Abstract

Macrophages and B cells are activated by unmethylated CpG-containing sequences in bacterial DNA. The lack of activity of self DNA has generally been attributed to CpG suppression and methylation, although the role of methylation is in doubt. The frequency of CpG in the mouse genome is 12.5% of Escherichia coli, with unmethylated CpG occurring at approximately 3% the frequency of E. coli. This suppression of CpG alone is insufficient to explain the inactivity of self DNA; vertebrate DNA was inactive at 100 micro g/ml, 3000 times the concentration at which E. coli DNA activity was observed. We sought to resolve why self DNA does not activate macrophages. Known active CpG motifs occurred in the mouse genome at 18% of random occurrence, similar to general CpG suppression. To examine the contribution of methylation, genomic DNAs were PCR amplified. Removal of methylation from the mouse genome revealed activity that was 23-fold lower than E. coli DNA, although there is only a 7-fold lower frequency of known active CpG motifs in the mouse genome. This discrepancy may be explained by G-rich sequences such as GGAGGGG, which potently inhibited activation and are found in greater frequency in the mouse than the E. coli genome. In summary, general CpG suppression, CpG methylation, inhibitory motifs, and saturable DNA uptake combined to explain the inactivity of self DNA. The immunostimulatory activity of DNA is determined by the frequency of unmethylated stimulatory sequences within an individual DNA strand and the ratio of stimulatory to inhibitory sequences.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646625     DOI: 10.4049/jimmunol.170.7.3614

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  62 in total

Review 1.  Nonviral DNA vectors for immunization and therapy: design and methods for their obtention.

Authors:  Ernesto G Rodríguez
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

2.  A toll-like receptor 9 (rs352140) variant is associated with placental inflammation in newborn infants.

Authors:  Vijender Karody; Shawn Reese; Navin Kumar; Jennifer Liedel; Jason Jarzembowski; Venkatesh Sampath
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-15

3.  The phasevarion: a genetic system controlling coordinated, random switching of expression of multiple genes.

Authors:  Yogitha N Srikhanta; Tina L Maguire; Katryn J Stacey; Sean M Grimmond; Michael P Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-31       Impact factor: 11.205

4.  Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.

Authors:  Maroof Hasan; Gabriela Lopez-Herrera; K Emelie M Blomberg; Jessica M Lindvall; Anna Berglöf; C I Edvard Smith; Leonardo Vargas
Journal:  Immunology       Date:  2007-08-28       Impact factor: 7.397

Review 5.  Traditional biochemical assays for studying toll-like receptor 9.

Authors:  Cynthia A Leifer; William A Rose; Fernando Botelho
Journal:  J Immunoassay Immunochem       Date:  2013

6.  Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo.

Authors:  Patric Lundberg; Paula Welander; Xiao Han; Edouard Cantin
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Safia Ogbi; Babak Baban; Jennifer C Sullivan; Takayuki Matsumoto; R Clinton Webb
Journal:  Cardiovasc Res       Date:  2015-04-24       Impact factor: 10.787

8.  Chloroquine Suppresses the Development of Hypertension in Spontaneously Hypertensive Rats.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Styliani Goulopoulou; Babak Baban; Takayuki Matsumoto; R Clinton Webb
Journal:  Am J Hypertens       Date:  2016-09-13       Impact factor: 2.689

9.  Age-associated epigenetic modifications in human DNA increase its immunogenicity.

Authors:  Anshu Agrawal; Jia Tay; Gi-Eun Yang; Sudhanshu Agrawal; Sudhir Gupta
Journal:  Aging (Albany NY)       Date:  2010-03-20       Impact factor: 5.682

10.  DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.

Authors:  Petar Lenert; Kei Yasuda; Liliana Busconi; Patrice Nelson; Courtney Fleenor; Radhika S Ratnabalasuriar; Peter L Nagy; Robert F Ashman; Ian R Rifkin; Ann Marshak-Rothstein
Journal:  Arthritis Res Ther       Date:  2009-05-28       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.